Drug Type Interleukins |
Synonyms Recombinant Human Interleukin-2, Inleusin, 英路因 |
Target |
Action agonists |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1997), |
Regulation- |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Malignant Pleural Effusion | China | 01 Jan 1997 | |
| Melanoma | China | 01 Jan 1997 | |
| Pulmonary Tuberculosis | China | 01 Jan 1997 | |
| Renal Cell Carcinoma | China | 01 Jan 1997 |






